Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Nature|August 6, 2025
Microglia regulate GABAergic neurogenesis in prenatal human brain through IGF1Diankun Yu, Samhita Jain, Andi Wangzhou, et al.
Helicobacter|February 27, 2016
Analysis of Gastric Microbiota by Pyrosequencing: Minor Role of Bacteria Other Than Helicobacter pylori in the Gastric CarcinogenesisHyun Jin Jo, Jaeyeon Kim, Nayoung Kim, et al.
The Journal of Biological Chemistry|July 12, 2025
Modulation of the PTPRS proteoglycan switch by antibodies binding to the membrane-proximal fibronectin-type III domainThales Hein Da Rosa, Sterling H Ramsey, Judy J Lee, et al.
Molecular Cancer Therapeutics|October 9, 2021
A Benzenesulfonamide-Based Mitochondrial Uncoupler Induces Endoplasmic Reticulum Stress and Immunogenic Cell Death in Epithelial Ovarian CancerFangfang Bi, Ziyan Jiang, Wonmin Park, et al.
The Journal of Pathology|June 3, 2015
Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesisJiamin Chen, Yemin Wang, Melissa K McMonechy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2017
Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot StudyRamesh K Ramanathan, Ronald L Korn, Natarajan Raghunand, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2017
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomaJennifer L Clarke, Annette M Molinaro, Juan R Cabrera, et al.
Gut and Liver|November 15, 2016
Dynamic Changes in Helicobacter pylori Status Following Gastric Cancer SurgeryKichul Yoon, Nayoung Kim, Jaeyeon Kim, et al.
Cancers|March 28, 2024
Natural Killer Cell Dysfunction in Premenopausal BRCA1 Mutation Carriers: A Potential Mechanism for Ovarian CarcinogenesisShaun Haran, Kantaraja Chindera, May Sabry, et al.
JCI Insight|September 30, 2025
Optimization of a synoviocyte-targeted biologic for inflammatory arthritis in combination or bispecific administration with TNF inhibitorsSterling H Ramsey, Zixuan Zhao, Megan C Lee, et al.
Pageof 11